Publications by authors named "A Dibie"
[ReTurn To work of coronary patient: RTT French multicentre study].
Ann Cardiol Angeiol (Paris)
November 2024
Introduction: Coronary heart disease remains one of the leading causes of morbidity and mortality, and is responsible for significant social costs. Resumption of work is an essential objective when this pathology concerns working patients. French data remain patchy and relatively old.
View Article and Find Full Text PDFBackground: Large datasets of transcatheter aortic valve implantation (TAVI) for pure aortic valve regurgitation (PAVR) are scarce.
Aims: We aimed to report procedural safety and long-term clinical events (CE) in a contemporary cohort of PAVR patients treated with new-generation devices (NGD).
Methods: Patients with grade III/IV PAVR enrolled in the FRANCE-TAVI Registry were selected.
Article Synopsis
- A study was conducted to evaluate the effectiveness of the polymer-free biolimus coated stent (BioFreedom) in a diverse patient population undergoing coronary interventions, specifically focusing on those with high bleeding risk (HBR) versus non-HBR patients.
- The study included 1497 patients and measured the incidence of target lesion failure (TLF) as its primary outcome, finding a higher occurrence of TLF in HBR patients (9.2%) compared to non-HBR patients (5.8%).
- Results indicated that HBR patients faced greater risks of cardiac death and target vessel myocardial infarction, while also experiencing higher bleeding rates, confirming the need for careful patient management in this high-risk group.
[Chronic Heart Failure and Telemedecine, remote monitoring : Interest and perspectives].
Ann Cardiol Angeiol (Paris)
November 2021
Chronic heart failure in France is responsible for 160 000 hospitalizations per year. The treatment of chronic heart failure is multidisciplinary. Telemedicine (TLM) reinforces the therapeutic arsenal of this chronic pathology by the use of remote monitoring (TLS) on patients followed outside the care structure.
View Article and Find Full Text PDFArticle Synopsis
- Surgical aortic valve replacement (SAVR) is recommended for low-risk patients, while the Heart Team should decide between transcatheter aortic valve implantation (TAVI) and surgery for others, with a preference for TAVI in older patients.
- A multicenter study surveyed 1,049 patients aged 75 and older to understand the role of age and surgical risk in treatment decisions for severe aortic stenosis, finding that TAVI was preferred in 71% of cases.
- The study revealed that as age increases, particularly after 80, the influence of surgical risk scores on treatment decisions decreases significantly, leading most patients to be referred for TAVI even if they have low surgical risk; however, 10%